Sign Up to like & get
recommendations!
0
Published in 2017 at "Cancer Gene Therapy"
DOI: 10.1038/cgt.2016.54
Abstract: We have recently witnessed substantial progress with immunotherapy for selected diseases. Checkpoint inhibitors and chimeric antigen receptor T (CAR-T) cells are among the most promising agents. Whereas much of the early success with CAR-T cells…
read more here.
Keywords:
opening portal;
immunosuppression liver;
immunotherapy;
tumors opening ... See more keywords